Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
albumin + immunoglobulin
- Development stage
- Phase 4
- Lead developer
- Grifols
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intravenous
01
Overview
A combination product containing human albumin and immunoglobulin. Albumin functions to maintain oncotic pressure, transport molecules, and regulate fluid balance, while immunoglobulin provides antibodies that strengthen the immune system by targeting pathogens. This combination may be used in conditions requiring both plasma protein replacement and immune system support.
- Brand names
- BisekoVerglob 500Verglob500Verglob-500
02
Targets
IgA (Immunoglobulin A)
Beyond the preview
Go deeper on albumin + immunoglobulin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on albumin + immunoglobulin.